79 related articles for article (PubMed ID: 7965751)
1. Nephrotoxicity and hepatotoxicity of 5,6-dichloro-4-thia-5-hexenoic acid: evidence for fatty acid beta-oxidation-dependent bioactivation.
Fitzsimmons ME; Baggs RB; Anders MW
J Pharmacol Exp Ther; 1994 Oct; 271(1):515-23. PubMed ID: 7965751
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid beta-oxidation-dependent bioactivation of halogenated thiaalkanoic acids in isolated rat hepatocytes.
Fitzsimmons ME; Anders MW
Chem Res Toxicol; 1993; 6(5):662-8. PubMed ID: 8292744
[TBL] [Abstract][Full Text] [Related]
3. Medium-chain acyl-CoA dehydrogenase- and enoyl-CoA hydratase-dependent bioactivation of 5,6-dichloro-4-thia-5-hexenoyl-CoA.
Fitzsimmons ME; Thorpe C; Anders MW
Biochemistry; 1995 Apr; 34(13):4276-86. PubMed ID: 7703241
[TBL] [Abstract][Full Text] [Related]
4. Elimination reactions in the medium-chain acyl-CoA dehydrogenase: bioactivation of cytotoxic 4-thiaalkanoic acids.
Baker-Malcolm JF; Haeffner-Gormley L; Wang L; Anders MW; Thorpe C
Biochemistry; 1998 Feb; 37(5):1383-93. PubMed ID: 9477967
[TBL] [Abstract][Full Text] [Related]
5. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
6. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
Vickers AE; Bentley P; Fisher RL
Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
[TBL] [Abstract][Full Text] [Related]
7. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships.
Tune BM; Hsu CY
J Pharmacol Exp Ther; 1994 Sep; 270(3):873-80. PubMed ID: 7932199
[TBL] [Abstract][Full Text] [Related]
9. The metabolic effects of thia fatty acids in rat liver depend on the position of the sulfur atom.
Gudbrandsen OA; Dyrøy E; Bohov P; Skorve J; Berge RK
Chem Biol Interact; 2005 Jun; 155(1-2):71-81. PubMed ID: 15949791
[TBL] [Abstract][Full Text] [Related]
10. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation.
Berge RK; Madsen L; Vaagenes H; Tronstad KJ; Göttlicher M; Rustan AC
Biochem J; 1999 Oct; 343 Pt 1(Pt 1):191-7. PubMed ID: 10493929
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
12. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
13. Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes.
Abdel-aleem S; Nada MA; Sayed-Ahmed M; Hendrickson SC; St Louis J; Walthall HP; Lowe JE
J Mol Cell Cardiol; 1996 May; 28(5):825-33. PubMed ID: 8762022
[TBL] [Abstract][Full Text] [Related]
14. A case of impairment of mitochondrial fatty acid beta-oxidation.
Hasegawa T; Hori N; Du W
Keio J Med; 2002 Jun; 51(2):100-6. PubMed ID: 12125906
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
[TBL] [Abstract][Full Text] [Related]
16. Carnitine deficiency disorders in children.
Stanley CA
Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
[TBL] [Abstract][Full Text] [Related]
17. Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity.
Guo W; Pirtskhalava T; Tchkonia T; Xie W; Thomou T; Han J; Wang T; Wong S; Cartwright A; Hegardt FG; Corkey BE; Kirkland JL
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1041-51. PubMed ID: 17148751
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.
Deschamps D; DeBeco V; Fisch C; Fromenty B; Guillouzo A; Pessayre D
Hepatology; 1994 Apr; 19(4):948-61. PubMed ID: 8138270
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between para-aminophenol toxicity in vivo and in vitro in female Sprague-Dawley rats.
Shao R; Tarloff JB
Fundam Appl Toxicol; 1996 Jun; 31(2):268-78. PubMed ID: 8789793
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
Geneve J; Hayat-Bonan B; Labbe G; Degott C; Letteron P; Freneaux E; Dinh TL; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1987 Sep; 242(3):1133-7. PubMed ID: 3116197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
